Your browser doesn't support javascript.
loading
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.
Wu, Yi-Long; Lu, Shun; Lu, You; Zhou, Jianying; Shi, Yuan-Kai; Sriuranpong, Virote; Ho, James C M; Ong, Choo Khoon; Tsai, Chun-Ming; Chung, Chin-Hee; Wilner, Keith D; Tang, Yiyun; Masters, Elizabeth T; Selaru, Paulina; Mok, Tony S.
Afiliação
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China. Electronic address: syylwu@live.cn.
  • Lu S; Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Jiao Tong University, Shanghai, People's Republic of China.
  • Lu Y; Department of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
  • Zhou J; Respiratory Department, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
  • Shi YK; Department of Medical Oncology, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
  • Sriuranpong V; Medical Oncology Unit, Department of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Ho JCM; Department of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
  • Ong CK; Department of Respiratory Medicine, Hospital Pulau Pinang, Pulau Pinang, Malaysia.
  • Tsai CM; Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China.
  • Chung CH; Pfizer Oncology, New York, New York.
  • Wilner KD; Pfizer Oncology, La Jolla, California.
  • Tang Y; Pfizer Oncology, La Jolla, California.
  • Masters ET; Pfizer Oncology, New York, New York.
  • Selaru P; Pfizer Oncology, La Jolla, California.
  • Mok TS; Department of Clinical Oncology, State Laboratory of South China, The Chinese University of Hong Kong, Hong Kong, People's Republic of China.
J Thorac Oncol ; 13(10): 1539-1548, 2018 10.
Article em En | MEDLINE | ID: mdl-29966800
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Crizotinibe / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Crizotinibe / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Thorac Oncol Ano de publicação: 2018 Tipo de documento: Article